(Q42168851)

English

Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patients

scientific article published on January 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

Mitsuhiro Takimoto

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Shogo Ohkoshi

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Takafumi Ichida

3

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Yasuo Takeda

4

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Minoru Nomoto

5

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Hitoshi Asakura

6

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Akira Naito

7

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Shigeki Mori

8

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Kojiro Hata

9

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Kentaro Igarashi

10

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Hidenori Hara

11

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Hironobu Ohta

12

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Kenji Soga

13

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Toshiaki Watanabe

14

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Tomoteru Kamimura

15

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

170-176

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Therapy of hepatitis C: overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A retrospective study of hepatitis C virus carriers in a local endemic town in Japan. A possible presence of asymptomatic carrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing incidence of hepatocellular carcinoma in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C: the clinical spectrum of the disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of specific antibody assay for genotyping of hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current therapy for chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C and hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma. A worldwide problem and the major risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of chronic viral hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://pubmed.ncbi.nlm.nih.gov/11837720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1013244326874

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42168851&oldid=2205096876"